Table 2.
Main clinical information for SARS-CoV-2 cases
n or mean ± s.d. (range) | |
---|---|
Total number of positive cases | 401 |
Origin of diagnosis | |
GP | 11 |
Hospital | 2 |
Diagnostic antigen test from Public Health records | 338 |
Antibody home-based lateral flow kits | 50 |
Number of infected participants with available information on date of diagnoses | 351 |
Days of SARS-CoV-2 infection before scan 2 | 141 ± 79 (35–407) |
Total number of hospitalised patients | 15 |
COVID-19 as primary cause | 11 |
COVID-19 as secondary cause | 4 |
Days of hospitalisation | 11.1 ± 11.0 (1–40) |
Critical care unit | 2 |
Invasive ventilation | 1 |
Continuous positive airway pressure | 1 |
Non-invasive ventilation | 1 |
Unspecified oxygen therapy | 1 |
Of the 401 participants in our SARS-CoV-2-positive group in our main analyses, 50 were identified as cases on the basis of two different antibody home-based lateral flow kits and do not have a date of diagnosis in their primary care or hospital records.